SINGAPORE – Media OutReach Newswire – 21 April 2026 – Esco Lifesciences Group (“Esco”) today announced the acq...
Zydus Lifesciences is set to launch a generic version of the weight-loss injection semaglutide next month. The drug will...
Zydus Lifesciences is in focus after receiving USFDA clearance with zero observations for its Ahmedabad facility and lau...
Zydus Lifesciences has achieved a significant milestone by obtaining tentative approval from the US FDA for Dapagliflozi...